kr313.60
2.24%
Stockholm, Sep 28, 05:29 pm CEST. Closed.
ISIN
SE0000195810
Symbol
BURE

Bure Equity Stock price

kr313.60
-13.40 4.10% 1M
+100.60 47.23% 6M
+66.80 27.07% YTD
+37.20 13.46% 1Y
+100.80 47.37% 3Y
-48.20 13.32% 5Y
+214.09 215.16% 10Y
+297.90 1,897.87% 20Y
Stockholm, Closing price Mon, Sep 28 2026
-7.20 2.24%
ISIN
SE0000195810
Symbol
BURE
Industry

Is Bure Equity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
kr23.2b
Enterprise Value
kr22.7b
Net debt
positive
Cash
kr564.0m
Shares outstanding
74.2m
Valuation (TTM | estimate)
P/E
4.8
P/S
94.4 | -
EV/Sales
92.1 | -
EV/FCF
38.2
P/B
0.9
Dividends
DPS
kr2.75
Yield 1Y | 5Y
0.9% | 0.9%
Growth 1Y | 5Y
0.0% | 6.6%
Payout 1Y | 3Y
-4.4% | 9.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
kr246.0m | -
EBITDA
kr155.0m
EBIT
kr150.0m
Net Income
kr5.0b
Free Cash Flow
kr594.0m
Growth (TTM | estimate)
Revenue
-4.3% | -
EBITDA
-1.9%
EBIT
-2.6%
Net Income
273.6%
Free Cash Flow
226.4%
Margin
Gross
-
EBITDA
63.0%
EBIT
61.0%
Net
2,043.9%
Free Cash Flow
241.5%
Financial Health
Equity Ratio
98.6%
Return on Equity
-23.6%
ROCE
0.6%
ROIC
-
Debt/Equity
0.0
More
EPS
kr67.4
FCF per Share
kr8.0
Short interest
-
Employees
12
Rev per Employee
kr21.3m

Bure Equity Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bure Equity forecast:

2x Hold
22%
7x Sell
78%

Analyst Opinions

9 Analysts have issued a Bure Equity forecast:

Hold
22%
Sell
78%

Financial data from Bure Equity

Jun '26
+/-
%
246 246
4% 4%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 60 60
12% 12%
24%
- Research and Development Expense - -
-
-
155 155
2% 2%
63%
- Depreciation and Amortization 5 5
25% 25%
2%
EBIT (Operating Income) EBIT 150 150
3% 3%
61%
Net Profit 5,028 5,028
274% 274%
2,044%

In millions SEK.

Don't miss a Thing! We will send you all news about Bure Equity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Bure Equity ABis an investment company with ownership interests in Nordic companies. The company is headquartered in Stockholm, Stockholm and currently employs 11 full-time employees. The firm specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.

Head office Sweden
CEO Mr. Blomquist
Employees 12
Website www.bure.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today